Copyright Reports & Markets. All rights reserved.

Global Marine Derived Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Marine Derived Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Mollusk
    • 1.3.3 Sponge
    • 1.3.4 Tunicate
    • 1.3.5 Fish
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Marine Derived Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Antitumor Drugs
    • 1.4.3 Anti-Cardiovascular Drugs
    • 1.4.4 Others
  • 1.5 Global Marine Derived Drugs Market Size & Forecast
    • 1.5.1 Global Marine Derived Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Marine Derived Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Marine Derived Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Seattle Genetics
    • 2.1.1 Seattle Genetics Details
    • 2.1.2 Seattle Genetics Major Business
    • 2.1.3 Seattle Genetics Marine Derived Drugs Product and Services
    • 2.1.4 Seattle Genetics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Seattle Genetics Recent Developments/Updates
  • 2.2 Eisai Co
    • 2.2.1 Eisai Co Details
    • 2.2.2 Eisai Co Major Business
    • 2.2.3 Eisai Co Marine Derived Drugs Product and Services
    • 2.2.4 Eisai Co Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Eisai Co Recent Developments/Updates
  • 2.3 Tekada
    • 2.3.1 Tekada Details
    • 2.3.2 Tekada Major Business
    • 2.3.3 Tekada Marine Derived Drugs Product and Services
    • 2.3.4 Tekada Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Tekada Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Marine Derived Drugs Product and Services
    • 2.4.4 Pfizer Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Pharma Mar
    • 2.5.1 Pharma Mar Details
    • 2.5.2 Pharma Mar Major Business
    • 2.5.3 Pharma Mar Marine Derived Drugs Product and Services
    • 2.5.4 Pharma Mar Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pharma Mar Recent Developments/Updates
  • 2.6 Johnson and Johnson
    • 2.6.1 Johnson and Johnson Details
    • 2.6.2 Johnson and Johnson Major Business
    • 2.6.3 Johnson and Johnson Marine Derived Drugs Product and Services
    • 2.6.4 Johnson and Johnson Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Johnson and Johnson Recent Developments/Updates
  • 2.7 GSK
    • 2.7.1 GSK Details
    • 2.7.2 GSK Major Business
    • 2.7.3 GSK Marine Derived Drugs Product and Services
    • 2.7.4 GSK Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GSK Recent Developments/Updates
  • 2.8 TerSera Therapeutics
    • 2.8.1 TerSera Therapeutics Details
    • 2.8.2 TerSera Therapeutics Major Business
    • 2.8.3 TerSera Therapeutics Marine Derived Drugs Product and Services
    • 2.8.4 TerSera Therapeutics Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 TerSera Therapeutics Recent Developments/Updates
  • 2.9 Teva
    • 2.9.1 Teva Details
    • 2.9.2 Teva Major Business
    • 2.9.3 Teva Marine Derived Drugs Product and Services
    • 2.9.4 Teva Marine Derived Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Teva Recent Developments/Updates

3 Competitive Environment: Marine Derived Drugs by Manufacturer

  • 3.1 Global Marine Derived Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Marine Derived Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Marine Derived Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Marine Derived Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Marine Derived Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Marine Derived Drugs Manufacturer Market Share in 2025
  • 3.5 Marine Derived Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Marine Derived Drugs Market: Region Footprint
    • 3.5.2 Marine Derived Drugs Market: Company Product Type Footprint
    • 3.5.3 Marine Derived Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Marine Derived Drugs Market Size by Region
    • 4.1.1 Global Marine Derived Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Marine Derived Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Marine Derived Drugs Average Price by Region (2021-2032)
  • 4.2 North America Marine Derived Drugs Consumption Value (2021-2032)
  • 4.3 Europe Marine Derived Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Marine Derived Drugs Consumption Value (2021-2032)
  • 4.5 South America Marine Derived Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Marine Derived Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Marine Derived Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Marine Derived Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Marine Derived Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Marine Derived Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Marine Derived Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Marine Derived Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Marine Derived Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Marine Derived Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Marine Derived Drugs Market Size by Country
    • 7.3.1 North America Marine Derived Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Marine Derived Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Marine Derived Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Marine Derived Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Marine Derived Drugs Market Size by Country
    • 8.3.1 Europe Marine Derived Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Marine Derived Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Marine Derived Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Marine Derived Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Marine Derived Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Marine Derived Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Marine Derived Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Marine Derived Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Marine Derived Drugs Market Size by Country
    • 10.3.1 South America Marine Derived Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Marine Derived Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Marine Derived Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Marine Derived Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Marine Derived Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Marine Derived Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Marine Derived Drugs Market Drivers
  • 12.2 Marine Derived Drugs Market Restraints
  • 12.3 Marine Derived Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Marine Derived Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Marine Derived Drugs
  • 13.3 Marine Derived Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Marine Derived Drugs Typical Distributors
  • 14.3 Marine Derived Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Marine Derived Drugs market size was valued at US$ 3076 million in 2025 and is forecast to a readjusted size of US$ 5444 million by 2032 with a CAGR of 8.6% during review period.
    Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
    The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
    Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
    North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
    In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
    This report is a detailed and comprehensive analysis for global Marine Derived Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Marine Derived Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Marine Derived Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Marine Derived Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Marine Derived Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Marine Derived Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Marine Derived Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, Johnson and Johnson, GSK, TerSera Therapeutics, Teva, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Marine Derived Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Mollusk
    Sponge
    Tunicate
    Fish
    Others
    Market segment by Application
    Antitumor Drugs
    Anti-Cardiovascular Drugs
    Others
    Major players covered
    Seattle Genetics
    Eisai Co
    Tekada
    Pfizer
    Pharma Mar
    Johnson and Johnson
    GSK
    TerSera Therapeutics
    Teva
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Marine Derived Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Marine Derived Drugs, with price, sales quantity, revenue, and global market share of Marine Derived Drugs from 2021 to 2026.
    Chapter 3, the Marine Derived Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Marine Derived Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Marine Derived Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Marine Derived Drugs.
    Chapter 14 and 15, to describe Marine Derived Drugs sales channel, distributors, customers, research findings and conclusion.

    Buy now